Practice SOCRA-CCRP Exam Online

Question 1

In accordance with ICH, which of the following is an acceptable protocol review frequency for an IRB?

A : 6 months

B : 12 months

C : 24 months

D : 36 months

Answer: B

Question 2

In accordance with the CFR, for at least how many years after the completion of a study must the clinical investigator provide the sponsor with relevant changes to financial information?

A : One year

B : Two years

C : Three years

D : Five years

Answer: B

Question 3

For an investigational new drug study that has potential side effects of myalgia, arthralgia, and lethargy, which of the following could serve as an acceptable consent statement?

A : You might experience adverse events of myalgia, arthralgia, and lethargy

B : You might have some muscle aches, joint pain, and tiredness

C : You might develop symptoms of myalgia, arthralgia, and tiredness

D : You might have some mild side effects while taking the investigational drug

Answer: B

Question 4

In order to adequately monitor a clinical trial, the monitor must be familiar with each of the following, EXCEPT the:

A : Written information to be provided to the subjects

B : Requirements for storage of the investigational product

C : Sponsor's SOPs

D : IRB/IEC requirements for reporting to the regulatory authority

Answer: D

Question 5

Which of the following should a clinical investigator include in a submission to an IRB/IEC for a Phase IV drug study?

A : The itemized study budget

B : The amount of payments and compensation to subjects

C : The drug development and marketing plan

D : The investigator's clinical trial agreement with the sponsor

Answer: B

Name:	Certified Clinical Research Professional (CCRP)
Exam Code:	SOCRA-CCRP
Certification:	SOCRA Certified Professional
Vendor:	SOCRA
Total Questions:	131
Last Updated:	Sep 29, 2026

SOCRA SOCRA-CCRP Answers